Uroselective alpha-blockade for benign prostatic hyperplasia: clinically significant or marketing savvy? (editorial)

Kaplan SA

首页> 外文期刊>Urology >Uroselective alpha-blockade for benign prostatic hyperplasia: clinically significant or marketing savvy? (editorial)

【24h】

Uroselective alpha-blockade for benign prostatic hyperplasia: clinically significant or marketing savvy? (editorial)

机译：良性前列腺增生的尿液选择性α受体阻滞剂：临床意义重大或精通营销？（社论）

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Urology》 |1999年第5期|共4页
作者
Kaplan SA;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类泌尿科学（泌尿生殖系疾病）;
关键词
Adrenergic alpha-Antagonists; Prostatic Hyperplasia; 肾上腺素能α拮抗剂; 前列腺增生;

机译：Adrenergic alpha-Antagonists;Prostatic Hyperplasia;肾上腺素能α拮抗剂;前列腺增生;

相似文献

外文文献
中文文献
专利

1. Uroselective alpha-blockade for benign prostatic hyperplasia: clinically significant or marketing savvy? (editorial) [J] . Kaplan SA Urology . 1999,第5期

机译：良性前列腺增生的尿液选择性α受体阻滞剂：临床意义重大或精通营销？（社论）
2. Discontinuation of alpha-blockade after initial treatment with finasteride and doxazosin in men with lower urinary tract symptoms and clinical evidence of benign prostatic hyperplasia. [J] . Baldwin KC, Ginsberg PC, Roehrborn CG, Urology . 2001,第2期

机译：在患有下尿路症状和良性前列腺增生的临床证据的男性中，非那雄胺和多沙唑嗪的初始治疗后中止α受体阻滞剂。
3. Neoadjuvant and adjuvant alpha-blockade improves early results of high-energy transurethral microwave thermotherapy for lower urinary tract symptoms of benign prostatic hyperplasia: a randomized, prospective clinical trial. [J] . Djavan B, Shariat S, Fakhari M, Urology . 1999,第2期

机译：新辅助剂和辅助性α受体阻滞剂改善了高能经尿道微波热疗法治疗前列腺增生的下尿路症状的早期结果：一项随机，前瞻性临床试验。
4. Clinical Decision Support System for Early Detection of Prostate Cancer from Benign Hyperplasia of Prostate [C] . Mustafa Ghaderzadeh MEDINFO . 2013

机译：从前列腺良性增生的早期检测前列腺癌的临床决策支持系统
5. The Feasibility of Fourier Transform Infrared Imaging Spectroscopy in Discriminating Benign Prostatic Hyperplasia From Prostate Cancer in Blood Serum Samples [D] . Monjardez, Geraldine. 2013

机译：傅里叶变换红外成像光谱技术从血清样品中区分前列腺癌与前列腺癌的可行性
6. Safety and Effectiveness of Once-Daily Tadalafil (5 mg) Therapy in Korean Men with Benign Prostatic Hyperplasia/Lower Urinary Tract Symptoms in a Real-World Clinical Setting: Results from a Post-Marketing Surveillance Study [O] . Ji Eon Won, Ji Yeon Chu, Hyunah Caroline Choi, 2018

机译：在现实世界中每日一次他达拉非（5毫克）疗法对良性前列腺增生/尿路下垂症状的韩国男性的安全性和有效性：上市后监测研究的结果
7. PUK2 A COST COMPARISON ANALYSIS OF TWO CLINICALLY UROSELECTIVE ALPHA BLOCKERS IN THE TREATMENT OF BENIGN PROSTATIC HYPERPLASIA [O] . MF Botteman, FC Lowe, M Naslund, 2004

机译：PUK2在治疗良性前列腺增生中的两种临床尿溶胶α阻滞剂的成本比较分析
8. Benign Prostatic Hyperplasia: Diagnosis and Treatment. Clinical PracticeGuideline Number 8; Quick Reference Guide for Clinicians Number 8; Treating Your Enlarged Prostate: Patient Guide [R] . 1994

机译：良性前列腺增生症：诊断和治疗。临床实践指南第8号;第8号临床医生快速参考指南;治疗扩大的前列腺：患者指南

Uroselective alpha-blockade for benign prostatic hyperplasia: clinically significant or marketing savvy? (editorial)

著录项

相似文献

相关主题

期刊订阅